Patients using these medications have shown significant weight loss, often ranging from 10% to 15% or more of their initial body weight, when combined with lifestyle interventions [1] [10]
A.Tamayo-TrujilloR.Paz-CruzE.Guevara-RamrezP.et al
Heres the good news: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) are NOT controlled substances
GLS inhibition (e.g., via BPTES) significantly reduces cell viability, demonstrating potent antitumor effects, especially in AR-independent cell lines (29, 236, 237)
However, adding Vitamin B12 offers more comprehensive health improvements
Adequate demographic representation across races and ethnic groups, geographic areas, sexes and genders, and age groups may lead to more robust and complete data that broaden the understanding of inter-individual response variability, which may in turn help expand the population of patients responsive to new medications such as tirzepatide